pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 7·1 min read
save

CDC’s cruise ship health chief Luis Rodríguez retires amid hantavirus outbreak on MV Hondius

May 7, 2026·read at STAT ↗Neutral

The Centers for Disease Control and Prevention announced that Luis Rodríguez, who has been with the Vessel Sanitation Program since 2010 and its chief since 2023, will retire.

His departure comes as a hantavirus outbreak on the cruise ship MV Hondius has drawn public attention to sanitation on cruise vessels.

The program experienced staffing turbulence last year, when full‑time employees were briefly laid off in April 2025 before the cuts were reversed.

The retirement underscores ongoing challenges for the CDC’s cruise ship health efforts as they continue to manage disease risks on passenger ships.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Official leading CDC’s cruise ship program retires”

read at STAT ↗
534 words · retrieved May 7
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2SanofiUltragenyx Pharmaceutical Inc.
topics
OncologyRare DiseaseType 2 Diabetes

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • May 15STAT+: FDA leadership shakeup widens following Makary’s departureSTAT
  • May 8Trump reportedly plans to fire FDA Commissioner MakarySTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Estuary channels $93M series A; OMass obtains $310MFierce Biotech
  • Oct 7Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, moreBioSpace